Celltrion Pharm · 영업(잠정)실적(공정공시)
Preliminary Operating Results (Fair Disclosure)
| Results Period | |||
| Current Period Results | 2026-07-01 | ~ | 2026-09-30 |
| Prior Period Results | 2026-04-01 | ~ | 2026-06-30 |
| Prior-Year Same Period Results | 2025-07-01 | ~ | 2025-09-30 |
| Current Period Cumulative Results | 2026-01-01 | ~ | 2026-09-30 |
| Prior-Year Same Period Cumulative Results | 2025-01-01 | ~ | 2025-09-30 |
| ※ 당해 정보는 확정치가 아닌 잠정치로 결산 결과 등에 따라 변경될 수 있음. | ||||||||
| 1. Performance Details | ||||||||
| Category (Unit: KRW m, %) | Current Period Results | Prior Period Results | vs. Prior Period | Prior-Year Same Period Results | YoY | |||
| (26.3Q) | (26.2Q) | Change (%) | Profit/loss turnaround | (25.3Q) | Change (%) | Profit/loss turnaround | ||
| Revenue | Current Results | 161,874 | 153,291 | 5.60 | - | 138,175 | 17.15 | - |
| Cumulative Results | 447,287 | - | - | - | 381,996 | 17.09 | - | |
| Operating Income | Current Results | 23,901 | 19,306 | 23.80 | - | 16,108 | 48.38 | - |
| Cumulative Results | 56,108 | - | - | - | 42,367 | 32.43 | - | |
| Income from continuing operations before income tax | Current Results | 23,515 | 18,518 | 26.99 | - | 15,124 | 55.49 | - |
| Cumulative Results | 53,869 | - | - | - | 39,214 | 37.37 | - | |
| Net Income | Current Results | 17,671 | 13,721 | 28.79 | - | 11,459 | 54.21 | - |
| Cumulative Results | 40,210 | - | - | - | 29,869 | 34.62 | - | |
| - | - | - | - | - | - | - | - | |
| 2. Information Provided | Information Provider | (주)셀트리온제약 경영관리팀 | ||||||
| Information Recipient | 기관, 일반투자자, 증권사 및 언론사 등 | |||||||
| Information release date (scheduled) | After Fair Disclosure | |||||||
| Information release time (scheduled) | - | |||||||
| Event Name (Venue) | - | |||||||
| 3. Contact | Chief Disclosure Officer (Name) | 박성준 상무 | ||||||
| Chief Disclosure Officer (Phone) | 070-8675-7681 | |||||||
| Disclosure Officer (Name) | 최시영 대리 | |||||||
| Disclosure Officer (Phone) | 070-8675-7681 | |||||||
| Department Name | 경영관리팀 | |||||||
| Department (Phone) | 070-8675-7681 | |||||||
| 4. Other Matters Relevant to Investment Decisions | - 상기 실적은 한국채택국제회계기준(K-IFRS)에 따라 작성된 개별재무제표 기준 영업(잠정) 실적입니다. - 상기 실적은 외부감사인의 회계감사가 완료되기 이전의 내부결산 자료로 감사결과에 따라 변경될 수 있습니다. | |||||||
| Related Disclosures | - | |||||||